SELECTBIO Conferences Cell Therapy Asia 2018
Cell Therapy Asia 2018
-亚洲细胞疗法年会:2018年-
日期:2018年12月6-7日
地点:日本,神户,Sheraton Kobe Bay Hotel & Towers

学会议长

Yuzo Toda

Yuzo Toda
Senior Executive Vice President and Chief Technical Officer, FUJIFILM Corporation

Norio Nakatsuji

Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

专题演讲者

Hiromitsu Nakauchi

Hiromitsu Nakauchi
Prof of Genetics, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine Project Professor, The Institute of Medical Science, Division of Stem Cell Therapy, Distinguished Professor Unit, The University of Tokyo

Kunihiko Suzuki

Kunihiko Suzuki
Vice Chairman & Member of the Board, Medinet Co. Ltd., Vice Chair, Forum for Innovative Regenerative Medicine (FIRM)

Terry Riss

Terry Riss
Global Strategic Marketing Manager Cell Health, Promega Corporation

Keisuke Goda

Keisuke Goda
Professor of Physical Chemistry, University of Tokyo, ImPACT Program Manager, Cabinet Office, Government of Japan

Shoji Takeuchi

Shoji Takeuchi
Professor and Director, Collaborative Research Center for Bio/Nano Hybrid Process, Institute of Industrial Science, The University of Tokyo

Yoshitsugu Shitaka

Yoshitsugu Shitaka
President, Astellas Institute for Regenerative Medicine

Masayo Takahashi

Masayo Takahashi
Professor, RIKEN Center for Biosystems Dynamics Research

概要

SELECTBIO主办的Cell Therapy Asia 2018将于兵库县神户市举行。

许多隶属于大学及药厂的研究人员将于本年会聚首,会议主题将聚焦于本领域中快速成长与进步的细胞疗法的干细胞、iPS细胞与研究及药物开发、细胞疗法的发展、CAR-T细胞疗法研究及包含临床应用的癌症免疫疗法研究等内容。

本届年会将广泛网罗细胞疗法与再生医疗领域生态系统的内容,并著眼于3D培养、类器官、微流体技术等建构微生理系统的技术上。

会议期间除了有大学及企业研究人员的演讲以及介绍最新研究成果的海报之外,也将举办展示会,欧洲、美国、亚太地区、日本的主要供应商将在此和与会者建立关系。

神户市具备了辅助生物医学领域研究的完善基础设施。可谓是举办本年会的最佳都市。

Cell Therapy Asia 2018包含以年轻研究者为对象的海报发表募集在内,京都大学教授中辻宪夫先生将担任一连串筹备作业的指导角色。由研究者所组成的审查团队,将从本届年会所募集到的海报摘要中评选出特别优异者,邀其进行口头演讲。

海报发表募集中

出席年会透过海报发表展现研究成果。意者请于规定期限内提交摘要以接受审查。

海报摘要提交期限:2018年11月30日

议程囊括下列主题

  • 3D培养与类器官
  • 细胞疗法的临床试验与商业化
  • 细胞疗法的脐带血与脐带血干细胞
  • 最新技术与新兴企业介绍
  • 癌症免疫疗法
    • 癌症治疗用的CAR-T细胞
  • 毒性测试、筛选、对应细胞疗法的iPS来源细胞
  • 间充质干细胞(MSC):在细胞疗法的应用可能性
  • 活体外微生理系统构筑的微流体平台
  • 细胞疗法相关药事法规的状况
  • 具备再生能力的干细胞胞外体
  • 细胞疗法的干细胞。再生医疗

募集赞助商与展商

详细赞助商与展商信息,请来信或来电询问日商环球讯息有限公司台湾分公司。

现阶段确定的演讲者

Shizuka Akieda, Chief Executive Officer, Cyfuse Biomedical K.K.
Toshihiko Ezashi, Research Associate Professor, The University of Missouri
Tatsuo Heki, Senior Expert, Regenerative Medicine Division, Fujifilm Corporation
Kennedy Okeyo, Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University
Hirofumi Suemori, Associate Professor, Laboratory of Embryonic Stem Cell Research, Institute for Frontier Life and Medical Sciences, Kyoto University
Masatoshi Suzuki, Associate Professor, Department of Comparative Biosciences and Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison
William G Whitford, Strategic Solutions Leader Bioprocess, GE Healthcare Life Sciences


Exhibition Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Chinese
Japanese
Korean
English



免费电子邮件通知服务